肺动脉搏动指数作为左心室辅助装置受者右心室衰竭预测因素的系统综述
该系统综述纳入32项研究共4756例患者,评估术前肺动脉搏动指数(PAPi)对左心室辅助装置(LVAD)植入后右心室衰竭(RVF)的预测价值。RVF发生率为27.48%(1307例)。发生RVF者术前PAPi较未发生者显著降低,加权均数差(95%CI)为-0.74 [-1.00, -0.49](P < .001)。作者推荐将PAPi与传统血流动力学参数联合用于LVAD受者RVF风险分层。
要点
- 32项研究共4756例LVAD受者中,RVF发生率为27.48%(1307例)。
- 发生RVF者术前PAPi加权均值为2.17(标准差2.36),未发生者为2.87(标准差3.21)。
- RVF组术前PAPi较无RVF组显著降低,加权均数差(95%CI)为-0.74 [-1.00, -0.49](P < .001)。
核心结论
- 该系统综述表明PAPi可作为LVAD植入后RVF的临床预测因素。
- 作者推荐将PAPi与传统血流动力学参数联合用于LVAD受者RVF风险分层。
研究设计与样本
- 系统综述,检索数据库纳入所有报告LVAD植入后PAPi与RVF关系的研究,共纳入32项研究、4756例患者。
- 收集数据包括患者数、患者特征、RVF发生率、PAPi、中心静脉压(CVP)、CVP/肺毛细血管楔压、三尖瓣环收缩期位移及右心室每搏做功指数。
主要发现
- RVF发生率为27.48%(1307例)。
- 发生RVF者术前PAPi加权均值为2.17(标准差2.36),未发生RVF者为2.87(标准差3.21)。
- RVF组术前PAPi较无RVF组显著降低,加权均数差(95%CI)为-0.74 [-1.00, -0.49](P < .001)。
- CVP、CVP/肺毛细血管楔压、三尖瓣环收缩期位移及右心室每搏做功指数亦被确认为LVAD植入后RVF的预测因素。
关键数值与推荐
- RVF发生率27.48%(1307例/4756例)。
- RVF组术前PAPi加权均值2.17(标准差2.36) vs 无RVF组2.87(标准差3.21)。
- RVF组较无RVF组术前PAPi加权均数差(95%CI)为-0.74 [-1.00, -0.49](P < .001)。
临床怎么用
- 作者推荐将PAPi与传统血流动力学参数联合用于LVAD受者RVF风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is critical to identify patients at increased risk of right ventricular failure (RVF) before left ventricular assist device (LVAD) implantation. Pulmonary artery pulsatility index (PAPi) is a hemodynamic parameter that is a specific measure of right ventricular function and may better identify LVAD recipients at risk for RVF. This systematic review analyzes the predictive value of preoperative PAPi to RVF in the setting of LVAD implantation. METHODS: Databases were searched for all studies reporting on PAPi and RVF after LVAD implantation. Data collected included: number of patients, patient characteristics, incidences of RVF, PAPi, central venous pressure (CVP), CVP/pulmonary capillary wedge pressure, tricuspid annular plane systolic excursion, and right ventricular stroke work index. RESULTS: Thirty-two studies (4,756 patients) were included in this review. The incidence of RVF was found to be 27.48% (1,307 patients). The weighted mean (standard deviation) of preoperative PAPi associated with RVF vs No RVF was 2.17 (2.36) and 2.87 (3.21), respectively. When comparing LVAD recipients with RVF and No RVF, patients who developed RVF had a significantly lower preoperative PAPi by a WMD (95% CI) of -0.74 [-1.00, -0.49] (p < .001). The remaining variables (CVP; CVP/pulmonary capillary wedge pressure; tricuspid annular plane systolic excursion; and right ventricular stroke work index) were also confirmed as predictors of RVF after LVAD implantation. CONCLUSIONS: This systematic review demonstrates the utility of PAPi as a clinical predictor of RVF after LVAD implantation. Based on our findings, we recommend that PAPi be used in conjunction with traditional hemodynamic parameters when risk stratifying LVAD recipients for RVF.
引用
- Essandoh M, Kumar N, Hussain N, et al. Pulmonary artery pulsatility index as a predictor of right ventricular failure in left ventricular assist device recipients: A systematic review. J Heart Lung Transplant. 2022. PMID: 35644726. doi:10.1016/j.healun.2022.04.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。